Prevalidation of the Embryonic Stem Cell Test (EST) - A new in vitro embryotoxicity test

Toxicology in Vitro

Volumn 13, Issue 4-5, 1999, Pages 675-681

  Scholz, G ^a   Genschow, E ^a   Pohl, I ^a   Bremer, S ^b   Paparella, M ^b   Raabe, H ^c   Southee, J ^d   Spielmann, H ^a  

^a Fed Inst Hlth Protect C   (Germany)

^b Europ Ctr Validation A   (Italy)

^c Institute for in Vitro Sciences   (United States)

^d Microbiological Associates Ltd   (United Kingdom)

Author keywords

cytotoxicity; Differentiation; Discriminant analysis; Embryonic stem cells; Embryotoxic potential; In vitro embryotoxicity; Myocard; Prediction model; Prevalidation study

Indexed keywords

ASCORBIC ACID; CAFFEINE; CYTARABINE; DEXAMETHASONE; FLUOROURACIL; HYDROXYUREA; ISONIAZID; PENICILLIN G; PHENYTOIN; RETINOIC ACID;

ANIMAL CELL; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DISCRIMINANT ANALYSIS; EMBRYOTOXICITY; HEART MUSCLE CELL; IN VITRO STUDY; NONHUMAN; REPRODUCTIVE TOXICITY; STEM CELL;

EID: 0032817508     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(99)00046-6     Document Type: Conference Paper

References (18)

1. Backhaus K., Erichson B., Plinke W. and Weiber R. (1996) Multivariate Analysemethoden. 8. Auflage, 591 Seiten, Springer Verlag, Berlin.
2. Balls M., Blaauboer B.J., Fentem J.H., Bruner L., Combes R.D., Ekwall B., Fielder R.J., Guillouzo A., Lewis R.W., Lovell D.P., Reinhardt C.A., Repetto G., Sladowski D., Spielmann H., Zucco F. Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM Workshop 5. ATLA. 23:1995;129-147.
3. Bortz J. (1993) Statistik. 3. Auflage, 753 Seiten, Springer Verlag, Berlin.
4. Brown N.A., Spielmann H., Bechter R., Flint O.P., Freeman S.J., Jelinek R.J., Koch E., Nau H., Newall D.R., Palmer A.K., Renault J-Y., Repetto M., Vogel R., Wiger R. Screening chemicals for reproductive toxicity: the current alternatives. The report and recommendations of an ECVAM/ETS workshop (ECVAM workshop 12). ATLA. 23:1995;868-882.
5. Curren R.D., Southee J.A., Spielmann H., Liebsch M., Fentem J.H., Balls M. The role of prevalidation in the development, validation and acceptance of alternative methods (the first report of the ECVAM Task Force on Prevalidation). ATLA. 23:1995;211-217.
6. Doetschmann T., Eistetter H.R., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. Journal of Embryology and Experimental Morphology. 87:1985;27-45.
7. Heuer J., Graeber I. M., Pohl I. and Spielmann H. (1994) Culture system for the differentiation of murine embryonic stem cells - a new approach to in vitro testing for embryotoxicity and for developmental immunotoxicology. In European Medicines Research. Edited by G. N. Fracchia, pp. 134-145. IOS Press; Amsterdam.
8. Lachenbruch P.A. An almost unbiased method of obtaining confidence intervals for the probability of misclassification in discriminant analysis. Biometrics. 23:1967;639-645.
9. Laschinski G., Vogel R., Spielmann H. Cytotoxity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reproductive Toxicology. 5:1991;57-64.
10. Maltsev V.A., Rohwedel J., Hescheler J., Wobus A. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mechanisms of Development. 44:1993;41-50.
11. Newall D.R., Beedles K.E. The stem cell test - a novel in vitro assay for teratogenic potential. Toxicology in Vitro. 8:1994;697-701.
12. Scholz G., Pohl I., Genschow E., Klemm M. and Spielmann H. (1999) Embryotoxicity screening using ES cells in vitro: correlation to in vivo teratogenicity. Cells, Tissues, Organs. In press.
13. Smith M.K., Kimmel G.L., Kochhar D.M., Shepard S.P., Spielberg S.P., Wilson J.G. A selection of candidate compounds for in vitro teratogenesis test validation. Teratogenesis, Carcinogenesis, and Mutagenesis. 3:1983;461-480.
14. Southee J.A., Curren R.D. A prevalidation process. Comments in Toxicology. 6:1997;27-35.
15. Spielmann H., Pohl I., Döring B., Liebsch M., Moldenhauer F. The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicology. 10:1997;119-127.
16. Spielmann H., Pohl I., Döring B. and Moldenhauer F. (1995) In vitro embryotoxicity assay using two permanent cell lines: mouse embryonic stem cells and 3T3 fibroblasts, Vol. 51, pp. 31A-32A. Abstracts of the 23rd. ETS conference 1995, Dublin: Teratology.
17. Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.L., Gearing D.P., Wagner E.F., Metcalf D., Nicola N.A., Gough N.M. Myeloid leucemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 336:1988;684-687.
18. 2+ channel blockers. Differentiation. 48:1991;173-182.